Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Thomas Jürgen Lehmeier has worked on the following 9 EPO patent applications which have been published in the last five years:

EP11716890

IMPROVED CELL CULTURE MEDIUM

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Henkel Breuer & Partner
Agent:
Multiple attorneys, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP13721353

CRYSTALLIZATION METHODS FOR PURIFICATION OF MONOCLONAL ANTIBODIES

IPC classification:
A61K 39/395, C07K 16/16
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP13753180

METHODS FOR PURIFICATION OF ANTIBODIES USING ALIPHATIC ALCOHOLS

IPC classification:
C07K 1/30, C07K 16/06
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP13792030

OPTIMIZED EXPRESSION CASSETTE FOR EXPRESSING A POLYPEPTIDE WITH HIGH YIELD

IPC classification:
C12N 5/10, C12N 15/85
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
PATENT GRANTED
EP14714386

METHOD OF SCREENING CELL CLONES

IPC classification:
C12N 15/10, G01N 33/569
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS
EP14753158

NOVEL SELECTION VECTORS AND METHODS OF SELECTING EUKARYOTIC HOST CELLS

IPC classification:
C07K 14/705, C12N 15/65, C12N 15/69, C12N 15/85
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP11717240

IMPROVED CELL CULTURE MEDIUM

IPC classification:
C12N 5/00
Applicant:
Novartis AG
Agent:
Markus Breuer, Henkel Breuer & Partner
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
PATENT GRANTED
EP14821860

NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

IPC classification:
C07K 16/00
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma AG
Status:
EXAMINATION IN PROGRESS
EP14821859

NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST

IPC classification:
C07K 16/00, C12N 5/00
Applicant:
Novartis AG
Agent:
Thomas Jürgen Lehmeier, Novartis Pharma GmbH
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature